Home › Trial NCT03573947
Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC
- Trial IDNCT03573947
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorJeffrey Clarke
- Enrollment46
- Start date2018-10-02
- ConditionsNon-small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.